Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...
GlobalData on MSN14h
FDA approves GSK’s Blujepa for uncomplicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
Interesting Engineering on MSN10h
New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 years
The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
21Alive7h
BRICK BY BRICK: Huntertown Elementary fundraiser supporting 1st grade student with cancer
When a first grader at Huntertown Elementary was diagnosed with cancer, staff and students didn’t just offer support - they took action.
The Villanovan16h
Meet the B+ Heroes
Everything we do, we do for our B+ Heroes,” is not only a phrase that fills the halls of Jake Nevin on the day of NOVAdance, but serves as a constant reminder of NOVAdance’s purpose throughout the ...